Jasper Therapeutics- Warrants (24/09/2026) Other Current Liabilities

The latest other current liabilities for JSPRW is $5.8M as of March 2026. That compares with $4.5M in the prior-year period — up 28.6% year over year. Investors often review this figure alongside Jasper Therapeutics- Warrants (24/09/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, JSPRW's other current liabilities moved from $4.5M to $5.8M — a 28.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Jasper Therapeutics- Warrants (24/09/2026)'s operating scale or balance-sheet position.

A other current liabilities figure of $5.8M for JSPRW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting JSPRW's other current liabilities ($5.8M), review year-over-year change from $4.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.